Ambrx Biopharma ROE 2020-2022 | AMAM
Current and historical return on equity (ROE) values for Ambrx Biopharma (AMAM) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
|Ambrx Biopharma ROE - Return on Equity Historical Data
||TTM Net Income
||Return on Equity
||Medical - Biomedical and Genetics
Ambrx Biopharma Inc. is a clinical stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop Engineered Precision Biologics. Ambrx Biopharma Inc. is based in SAN DIEGO.